ConductScience.org, home

Paper6345019

Adjuvant oral Razoxane (ICRF 159) in resectable colo-rectal cancer.

Slevin ML and 2 others. Cancer Chemother Pharmacol, 1983. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Adjuvant oral Razoxane (ICRF 159) in resectable colo-rectal cancer. Papers, record 6345019. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6345019

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Adjuvant oral Razoxane (ICRF 159) in resectable colo-rectal cancer.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1983
PubMed
Publication types
Clinical Trial, Letter, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0
iCite
Revised in PubMed
2019-08-29
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Slevin MLM L
2Harvey VJV J
3Wrigley PFP F

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Colonic NeoplasmsMajor topic
PiperazinesMajor topic
RazoxaneMajor topic
Rectal NeoplasmsMajor topic
Clinical Trials as Topic
Humans

References4

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16186375Adjuvant chemotherapy of large bowel cancer.Cancer Treat Rev1982https://conductscience.org/library/papers/6186375PubMed
2623960The survival of patients with colorectal cancer treated in a regional hospital.Br J Surg1978https://conductscience.org/library/papers/623960PubMed
37127660Adjuvant oral razoxane (ICRF-159) in resectable colorectal cancer.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/7127660PubMed
4795448Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.Br J Cancer1976https://conductscience.org/library/papers/795448PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6345019

GET https://conductscience.org/api/papers/v1/6345019/authors